DAR-AL-HANDASAH
12.8.2024 16:52:32 CEST | Business Wire | Press release
Ethiopian Airlines Group has announced plans to build Africa’s largest airport in Abusera – a critical element of Ethiopian’s 15-year strategic plan to become one of the most competitive aviation groups in the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240812311709/en/
Ethiopian Airlines Group CEO Mesfin Tasew and Dar’s Director of Operations in Ethiopia Tariq Al-Qanni sign consultancy contract for new Abusera International Airport. (Photo: AETOSWire)
The airport’s location allows for progressive growth, empowering the airline to meet the International Air Transport Association’s forecasts of more than 200% growth over the next decade – growing beyond Bole International Airport, which offers no possibilities for significant expansion. Abusera’s lower altitude will elevate aircraft take-off performance, while an express rail link to Addis Ababa facilitates connectivity.
In its first phase scheduled for 2029, the airport will have capacity for 60 million passengers annually – almost three times Africa’s current busiest airport – creating thousands of jobs to serve Ethiopian’s expanding customer base and fleet. Ultimately, the airport will serve 110 million passengers annually – four times the capacity of Bole International Airport.
Ethiopian’s CEO Mesfin Tasew stated: “With its exceptional capacity and world-class facilities, this new airport promises to elevate African aviation.”
To deliver this transformational new project, Ethiopian Airlines awarded a consultancy contract to a consortium led by Dar Al-Handasah Consultants (Shair and Partners), with Zaha Hadid Architects (ZHA), Pascall+Watson Architects, Landrum&Brown, and TY Lin.
Dar, TY Lin, and Landrum&Brown belong to Sidara, a global collaborative that ranks 1st in aviation (Engineering News Record 2023). ZHA brings award-winning design capabilities and a global track-record of acclaimed airport projects, while Pascall+Watson Architects has successfully completed over 2,000 aviation projects across 70 airports.
Collectively, these companies will cover technical advisory, engineering, project management, and construction supervision services for 600,000 m2 of passenger facilities, 126,000 m2 of airline support facilities, two Code 4E parallel runways along with associated airfield infrastructure, and other major airport facilities and infrastructure.
About Ethiopian Airlines Group
Ethiopian is one of the fastest-growing airlines globally and the largest in Africa. Building on a highly successful 78-year track record, Ethiopian operates Africa’s most modern fleet to more than 150 destinations across five continents.
https://www.ethiopianairlines.com/et
About Dar
Dar provides design, planning, engineering, and management services for buildings, cities, transportation, and infrastructure projects.
About Zaha Hadid Architects (ZHA)
Founded 45 years ago in London, ZHA offers architecture, design, and planning services worldwide.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240812311709/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release
Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 21:30:00 CET | Press release
Obtains Interim Approval to Access $125 Million of DIP FinancingGlobal Operations and Services to Customers Continue in Normal Course Without Interruption During Restructuring Process; All Trade Vendors and Suppliers to be Paid in Full Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom